Companies /Healthcare

Pulse Biosciences Inc

NASDAQ: PLSE Medical Instruments & Supplies
Today · % change

Fundamentals

Market Cap
$3.5B
Revenue (TTM)
$1.2M
EPS (TTM)
$-1.17
52-Week Range
$13 – $51
Street Target
$45.25

About Pulse Biosciences

Pulse Biosciences, Inc. is a pioneering bioelectric medicine company known for its CellFX System. This innovative platform uses nano-second pulses of electrical energy to precisely target and eliminate specific cells without harming surrounding tissue. Developed with its unique Nano-Pulse Stimulation technology, the system offers a non-thermal approach to treating various medical conditions. Originally named Electroblate, Inc., the company rebranded to Pulse Biosciences in 2015 and is based in Hayward, California.

PLSE Coverage